Helaakoski V et al
Real Fat Loss
Dont mention GLP-1s: Although 59% of diners would be likely to order smaller, protein-based menu items, over 37% say they are absolutely not interested in a menu labeled as GLP-1 meaning there is interest in the offering but not the identity 7
Current pharmacy coverage does not include GLP-1s for weight loss, unless your group has elected the benefit, for the many of the reasons outlined in the study
Risk of serious side effects such as thyroid cancer, kidney problems, pancreatitis, gallbladder issues, and more, if you take semaglutide without a proper medical evaluation (health history and exam)
In the context of Retatrutide research, GCGR activation is studied primarily for its energy expenditure effects particularly increased thermogenesis and hepatic fat oxidation which add a distinct and significant metabolic dimension to the GLP-1R and GIPR incretin effects already present in dual agonists like Tirzepatide